Edge Therapeutics competitorsClear all

Edge Therapeutics's top competitors include AbbVie, MyoKardia, Athersys and Reata Pharmaceuticals.
Edge Therapeutics
Edge Therapeutics
Edge Therapeutics, a clinical-stage biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
AbbVie
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Founding Date
Founding Date
2009
Founding Date
2013
Founding Date
2012
Founding Date
1995
Founding Date
2002
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Berkeley Heights, US HQ
Locations
Lake Bluff, US HQ
Alger, DZ
Buenos Aires, AR
Mascot, AU
Wien, AT
Wavre, BE
Sarajevo, BA
see more
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Plano, US HQ
Irving, US
Employees
Employees
N/A
Employees
30,000
Employees
23542% increase
Employees
8311% increase
Employees
22079% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
165.4 b
Valuation ($)
4.6 b
Valuation ($)
547.1 m
Valuation ($)
4.2 b
Twitter followers
Twitter followers
N/A
Twitter followers
63.1 k
Twitter followers
817
Twitter followers
1.8 k
Twitter followers
890
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
60
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
22
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
15.2
Average likes per tweet (last 30 days)
22.3
Average likes per tweet (last 30 days)
36.1
Average likes per tweet (last 30 days)
6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
96.67%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
90.91%
Alexa Website Rank
Alexa Website Rank
338857
Alexa Website Rank
129532
Alexa Website Rank
411899
Alexa Website Rank
322595
Alexa Website Rank
229923
Employee Rating
Employee Rating
0
Employee Rating
3.8
Employee Rating
4.4
Employee Rating
5.0
Employee Rating
4.0

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$33.3b (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$5.6m (FY, 2019)
Revenue (est.)
$26.5m (FY, 2019)
Net income
Net income
($7m) (FY, 2019)
Net income
$7.9b (FY, 2019)
Net income
($276.2m) (FY, 2019)
Net income
($44.6m) (FY, 2019)
Net income
($290.2m) (FY, 2019)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
2 (FY, 2018)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
240 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2018)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2018)
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2018)
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 101.5m
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 9m
Total funding raised
$ 468.9m
For sources of this data, please see the company profile

View company profiles

AbbVie
HQ
Lake Bluff, US
Employees
30,000

AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company